Regarding full details of the resolutions, referral is made to the notice convening the general meeting and the complete proposals. The notice convening the general meeting and the complete proposals are available at the company's website, www.sedanamedical.com.
Adoption of the income statements and the balance sheets
The general meeting resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet for the financial year 2023.
Allocation of the results
The general meeting resolved, in accordance with the board's proposal, that no dividend shall be paid for the financial year 2023 and that the company's available funds shall be balanced in a new account.
Discharge from liability
The general meeting discharged each who had held the position as board member during the financial year 2023 and the CEO from personal liability.
Board and auditors
The general meeting resolved, in accordance with the nomination committee's proposal, that the board shall be composed of five directors with no deputies and that the company shall have one auditor with no deputy.
The general meeting resolved, in accordance with the nomination committee's proposal, that fees to the directors shall be paid in the amount of
The general meeting resolved, in accordance with the nomination committee's proposal, that remuneration to the auditor shall be paid in accordance with approved invoices.
The general meeting resolved, in accordance with the nomination committee's proposal, to re-elect
The general meeting resolved, in accordance with the nomination committee's proposal, to re-elect the registered accounting firm Öhrlings
Approval of remuneration report
The general meeting resolved, in accordance with the board's proposal, to approve the board's remuneration report.
Issue authorization
The general meeting resolved, in accordance with the board's proposal, to authorize the board to, at one or more occasions during the period until the next annual general meeting, with or without deviation from the shareholders' preferential rights, resolve upon new share issues. By new share issue resolutions made by exercise of the authorization, with deviation from the shareholders' preferential rights, the company's share capital may not be increased by an amount exceeding ten percent of the share capital in the company at the time when the authorization is exercised for the first time.
Guidelines for remuneration to senior executives
The general meeting resolved, in accordance with the board's proposal, on guidelines for salaries and other remuneration to senior executives.
LTI 2024
The general meeting resolved, in accordance with the board's proposal, on a performance based incentive program for up to 25 employees in the
_________________
For additional information, please contact:
ir@sedanamedical.com
About
https://news.cision.com/sedana-medical/r/report-from-sedana-medical-s-annual-general-meeting-on-22-may-2024,c3986287
https://mb.cision.com/Main/15764/3986287/2815310.pdf
(c) 2024 Cision. All rights reserved., source